Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Non-adherence to essential medications represents an important public health problem. Little is known about the frequency with which patients fail to fill prescriptions when new medications are started (“primary non-adherence”) or predictors of failure to fill.
Evaluate primary non-adherence in community-based practices and identify predictors of non-adherence.
75,589 patients treated by 1,217 prescribers in the first year of a community-based e-prescribing initiative.
We compiled all e-prescriptions written over a 12-month period and used filled claims to identify filled prescriptions. We calculated primary adherence and non-adherence rates for all e-prescriptions and for new medication starts and compared the rates across patient and medication characteristics. Using multivariable regressions analyses, we examined which characteristics were associated with non-adherence.
Primary medication non-adherence.
Of 195,930 e-prescriptions, 151,837 (78%) were filled. Of 82,245 e-prescriptions for new medications, 58,984 (72%) were filled. Primary adherence rates were higher for prescriptions written by primary care specialists, especially pediatricians (84%). Patients aged 18 and younger filled prescriptions at the highest rate (87%). In multivariate analyses, medication class was the strongest predictor of adherence, and non-adherence was common for newly prescribed medications treating chronic conditions such as hypertension (28.4%), hyperlipidemia (28.2%), and diabetes (31.4%).
Many e-prescriptions were not filled. Previous studies of medication non-adherence failed to capture these prescriptions. Efforts to increase primary adherence could dramatically improve the effectiveness of medication therapy. Interventions that target specific medication classes may be most effective.
- Burwen DR, Galusha DH, Lewis JM, et al. National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the medicare health care quality improvement program. Arch Intern Med. 2003;163:1430–9. CrossRef
- Ganz DA, Glynn RJ, Mogun H, et al. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med. 2000;15:776–81. CrossRef
- Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140:714–20.
- Jencks SF, Huff ED, Cuerdon T. Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. JAMA. 2003;289:305–12. CrossRef
- McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635–45. CrossRef
- Shrank WH, Asch SM, Adams J, et al. The quality of pharmacologic care for adults in the United States. Med Care. 2006;44:936–45. CrossRef
- Benner J, Glynn R, Mogun H, Neumann P, Weinstein M, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455–61. CrossRef
- Matsui D, Joubert G, Dykxhoorn S, Rieder M. Compliance with prescription filling in the pediatric emergency department. Arch Pediatr Adolesc Med. 2000;154(2):195–8.
- O’Connor PJ. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Int Med. 2006;166:1802–4. CrossRef
- Osterberg L, Blaschke T. Drug therapy-adherence to medication. N Engl J Med. 2005;353(5):487–97. CrossRef
- Partridge A, Wang P, Winer E, Avorn J. Non-adherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003;21:602–6. CrossRef
- Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002;94:652–61.
- Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the department of veterans affairs. Am J Med. 2007;120:26–32. CrossRef
- Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836–41. CrossRef
- Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166:1842–7. CrossRef
- Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–30. CrossRef
- Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160(1):31–7.
- Enhancing Prescription Medicine Adherence: A National Action Plan. 2007. (Accessed January 5, 2010, at http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf. .)
- World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
- Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565–74. CrossRef
- Beardon PHG, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. Br Med J. 1993;307(6908):846–8. CrossRef
- Ekedahl A, Mansson N. Unclaimed prescriptions after automated prescription transmittals to pharmacies. Pharm World Sci. 2004;26:26–31. CrossRef
- Wamala S, Merlo J, Bostrom G, Hogstedt C, Agren G. Socioeconomic disadvantage and primary non-adherence with medication in Sweden. Int J Qual Health Care. 2007;19:134–40. CrossRef
- Wroth TH, Pathman DE. Primary medication adherence in a rural population: the role of the patient-physician relationship and satisfaction with care. J Am Board Fam Med. 2006;19:478–86. CrossRef
- Bell DS, Marken RS, Meili RC, et al. Recommendations for comparing electronic prescribing systems: results of an expert consensus process. Health Affairs 2004;Jan-Jun;Suppl Web Exclusives:W4-305-17.
- Shah NR, Hirsch AG, Zacker C, Taylor S, Wood GC, Stewart W. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med. 2008;24:233–7. CrossRef
- Shah NR, Hirsch AG, Zacker C, et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens. 2009;22:392–6. CrossRef
- Lapane KL, Dubé C, Schneider KL, Quilliam BJ. Patient perceptions regarding electronic prescriptions: is the geriatric patient ready? J Am Geriatr Soc. 2007;55:1254–9. CrossRef
- Fischer MA, Stedman MR, Vogeli C, Ferris TG, Weissman JS. Uptake of electronic prescribing in community-based practices. J Gen Intern Med. 2008;23:358–63. CrossRef
- Total prevalence of diabetes in the United States, all ages, 2005. 2005. (Accessed January 5, 2010, at http://www.cdc.gov/diabetes/pubs/estimates05.htm#prev, at
- Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289(19):2560–72. CrossRef
- Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117(8):1028–36. CrossRef
- Solomon MD, Goldman DP, Joyce GF, Escarce JJ. Cost sharing and the initiation of drug therapy for the chronically Ill. Arch Intern Med. 2009;169(8):740–8. CrossRef
- Shrank WH, Hoang T, Ettner SL, et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Int Med. 2006;166:332–7. CrossRef
- Shrank WH, Fox SA, Kirk A, et al. The effect of pharmacy benefit design on patient-physician communication about costs. J Gen Intern Med. 2006;21:334–9. CrossRef
- Barbaro M, Abelson R. Relief for Some but Maybe Not Many in Wal-Mart Plan for $4 Generic Drugs The New York Times 2006 September 22, 2006.
- Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions
Journal of General Internal Medicine
Volume 25, Issue 4 , pp 284-290
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- electronic prescribing
- health information technology
- Industry Sectors
- Author Affiliations
- 1. Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA, 02120, USA
- 2. Institute for Health Policy, Massachusetts General Hospital, Boston, MA, USA